Arabic Arabic English English French French German German

New understanding of ovarian follicle development may lead to novel reproductive therapies

For the first time, researchers have shown how Mullerian inhibiting substance (MIS), also known as anti-Mullerian hormone, a key reproductive hormone, suppresses follicle development and prevents ovulation in females. “Understanding the mechanism of follicle development by MIS opens the door to creating novel approaches to contraception, preserving the eggs of young girls undergoing chemotherapy, enhancing the success of fertility treatment, and potentially delaying menopause,” says David Pépin, Ph.D., an associate molecular biologist in the Department of Surgery at Massachusetts General Hospital (MGH) and senior author of new research published in the Proceedings of the National Academy of Sciences (PNAS). Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Intranasal influenza vaccine enhances immune response and offers broad protection, researchers find

Next Post

3D ‘lung-on-a-chip’ model developed to test new therapies for COVID-19 and other lung conditions

Related Posts